电化学治疗转移性恶性黑色素瘤:InspECT前瞻性队列研究
151例患者中114例有≥60天随访,84例(74%)达总体缓解;394个病灶中306个(78%)达总体缓解,229个(58%)达完全缓解。1年总生存67%(95%CI 57-77%),黑色素瘤特异生存74%(95%CI 64-84%),未报告严重不良事件。
要点
- ECT对黑色素瘤皮肤转移病灶总体缓解率78%、完全缓解率58%。
- 肿瘤<3 cm、覆盖深部边缘与完全缓解显著相关。
- 无内脏转移、覆盖深部边缘与总体缓解正相关。
核心结论
- ECT是黑色素瘤皮肤转移的高效局部治疗,本研究中未观察到严重不良事件。
- 在特定临床因素存在时,ECT可作为局部肿瘤控制的替代或全身治疗辅助手段。
研究设计与样本
- 共识别151例转移性黑色素瘤患者,其中114例随访≥60天。
- ECT采用瘤内或静脉注射博来霉素后施加电脉冲,局部或全身麻醉下进行。
主要发现
- 114例可评估患者中84例(74%)达总体缓解(完全缓解+部分缓解)。
- 394个治疗病灶中306个(78%)达总体缓解,229个(58%)达完全缓解。
- 多因素分析中与总体缓解正相关的因素包括覆盖深部边缘、无内脏转移、存在淋巴水肿及治疗非放疗区域。
- 与完全缓解显著相关的因素包括覆盖深部边缘、治疗区域既往放疗及肿瘤大小<3 cm。
- 1年总生存67%(95%CI 57-77%),黑色素瘤特异生存74%(95%CI 64-84%)。
临床怎么用
- 对黑色素瘤皮肤转移灶可考虑ECT作为局部控制手段,尤其肿瘤<3 cm且能覆盖深部边缘时。
- 无内脏转移、存在淋巴水肿或非放疗区域病灶者总体缓解可能性更高。
- 治疗区域既往放疗与完全缓解相关,但仍需结合个体情况评估。
局限性
- 151例中仅114例有≥60天随访数据,随访不完整可能影响结果解释。
- 为单臂前瞻性队列研究,缺乏与既定局部治疗的随机对照比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: (ECT) is an effective local treatment for cutaneous metastasis. Treatment involves the administration of chemotherapeutic drugs followed by delivery of electrical pulses to the tumour. OBJECTIVES: To investigate the effectiveness of ECT in cutaneous metastases of melanoma and to identify factors that affect (beneficially or adversely) the outcome. METHODS: Thirteen cancer centres in the International Network for Sharing Practices on Electrochemotherapy consecutively and prospectively uploaded data to a common database. ECT consisted of intratumoral or intravenous injection of bleomycin, followed by application of electric pulses under local or general anaesthesia. RESULTS: In total, 151 patients with metastatic melanoma were identified from the database, 114 of whom had follow-up data of 60 days or more. Eighty-four of these patients (74%) experienced an overall response (OR = complete response + partial response). Overall, 394 lesions were treated, of which 306 (78%) showed OR, with 229 showing complete response (58%). In multivariate analysis, factors positively associated with overall response were coverage of deep margins, absence of visceral metastases, presence of lymphoedema and treatment of nonirradiated areas. Factors significantly associated with complete response to ECT treatment were coverage of deep margins, previous irradiation of the treated area and tumour size (< 3 cm). One-year overall survival in this cohort of patients was 67% (95% confidence interval 57-77%), while melanoma-specific survival was 74% (95% confidence interval 64-84%). No serious adverse events were reported, and the treatment was in general very well tolerated. CONCLUSIONS: ECT is a highly effective local treatment for melanoma metastases in the skin, with no severe adverse effects noted in this study. In the presence of certain clinical factors, ECT may be considered for local tumour control as an alternative to established local treatments, or as an adjunct to systemic treatments.
引用
- Kunte C, Letulé V, Gehl J, et al. Electrochemotherapy in the treatment of metastatic malignant melanoma: a prospective cohort study by InspECT. Br J Dermatol. 2017. PMID: 28118487. doi:10.1111/bjd.15340
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。